PMID: 11918537Mar 29, 2002Paper

RANK (receptor activator of nuclear factor-kappaB) and RANKL expression in multiple myeloma

British Journal of Haematology
Sophie RouxXavier Mariette

Abstract

The new members of the tumour necrosis factor (TNF) receptor-ligand family, receptor activator of nuclear factor-kappaB ligand (RANKL) and its receptor RANK, play a crucial role in osteoclast differentiation and activation. An increased expression of RANKL and/or RANK may be involved in the excessive bone resorption observed in multiple myeloma (MM). We used immunohistochemistry to study RANK and RANKL expression in bone marrow (BM) biopsies obtained at diagnosis in 15 MM patients, six patients with monoclonal gammopathy of undetermined significance (MGUS) and 10 normal BM biopsies. Plasma cells were not labelled with anti-RANKL or anti-RANK antibodies. In all biopsies, RANKL was expressed in endosteal bone surface, around vessels and in cells characterized by cytoplasmic expansions. These last cells did not express CD45 and were vimentin positive, corresponding to bone marrow stromal cells. Numerous stromal cells expressed RANKL in MM and MGUS specimens, with a greater expression in MM than in MGUS. Very few cells were stained with anti-RANKL in normal BM specimens. With the anti-RANK antibody, small mononuclear cells in the bone microenvironment were positive and were identified as erythroblast cells. In conclusion, we showed...Continue Reading

References

May 8, 1997·Biochemical and Biophysical Research Communications·E TsudaK Higashio
May 9, 1998·Proceedings of the National Academy of Sciences of the United States of America·H YasudaT Suda
Jan 8, 1999·Biochemical and Biophysical Research Communications·N NakagawaK Higashio
Jan 26, 2000·Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research·L C HofbauerB L Riggs

❮ Previous
Next ❯

Citations

Dec 20, 2011·Endocrine·G MazziottiA Giustina
Jan 7, 2011·Cancer Microenvironment : Official Journal of the International Cancer Microenvironment Society·Dov Zipori
Jun 7, 2005·Biochemical and Biophysical Research Communications·Ivana ZavrskiOrhan Sezer
May 7, 2003·The Lancet Oncology·Andrew J AshcroftGareth J Morgan
Jul 20, 2007·Arthritis Research & Therapy·Babatunde O Oyajobi
May 16, 2008·Clinical Journal of the American Society of Nephrology : CJASN·Samirah Abreu GomesIta Pfeferman Heilberg
Apr 2, 2014·Journal of Clinical Biochemistry and Nutrition·Miki TadaishiYoshiko Ishimi
Oct 24, 2007·Clinical & Experimental Metastasis·Isabelle Vande BroekIvan Van Riet
Oct 21, 2003·Leukemia & Lymphoma·Sophie Barillé-Nion, Régis Bataille
Apr 23, 2004·Leukemia & Lymphoma·Nicola CalvaniFranco Dammacco
Apr 7, 2009·Expert Opinion on Biological Therapy·Evangelos TerposMeletios-Athanassios Dimopoulos
Dec 12, 2007·Best Practice & Research. Clinical Haematology·Klaus PodarKenneth C Anderson
Nov 13, 2007·Hematology/oncology Clinics of North America·Constantine S MitsiadesKenneth C Anderson
Sep 15, 2005·British Journal of Haematology·Nicola CalvaniFranco Dammacco
Jun 5, 2004·Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research·Pirow J BekkerAlex M DePaoli
Jul 9, 2003·Immunological Reviews·Robert A Kyle, S Vincent Rajkumar
Jul 9, 2003·Immunological Reviews·Michael Potter
Nov 25, 2003·British Journal of Haematology·Evangelos TerposAmin Rahemtulla
Jan 26, 2006·Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research·Pirow J BekkerAlex M DePaoli
Aug 31, 2006·Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research·Gerald J AtkinsAndrew C W Zannettino
Feb 20, 2013·International Journal of Cancer. Journal International Du Cancer·Li-Sha AiYu Hu
Nov 25, 2004·Cytokine & Growth Factor Reviews·Sandrine TheoleyreDominique Heymann
Sep 15, 2004·Biochimica Et Biophysica Acta·Y WittrantF Rédini
Jun 13, 2006·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Ulrike HeiderOrhan Sezer
Jun 13, 2006·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Constantine S MitsiadesKenneth C Anderson
Feb 6, 2003·Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research·S RouxX Mariette
Jul 3, 2013·Clinical & Developmental Immunology·Angela OrangerMaria Grano
Sep 16, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Anas Younes, Marshall E Kadin
Jan 23, 2018·Histochemistry and Cell Biology·Riko KitazawaSohei Kitazawa
Jan 13, 2018·Journal of Cellular Physiology·Yuvaraj SambandamSakamuri V Reddy
Jan 28, 2003·Cancer·Emilia Mia Sordillo, Roger Niles Pearse
Jan 28, 2003·Cancer·Peter I CroucherKarin Vanderkerken
Sep 25, 2007·Journal of Cellular Biochemistry·Kumaran SundaramSakamuri V Reddy

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.